END-STAGE HEART FAILURE
Clinical trials for END-STAGE HEART FAILURE explained in plain language.
Never miss a new study
Get alerted when new END-STAGE HEART FAILURE trials appear
Sign up with your email to follow new studies for END-STAGE HEART FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart pump could outperform drugs in advanced heart failure
Disease control Recruiting nowThis study tests whether a mechanical heart pump (LVAD) works better than standard medications for people with end-stage heart failure who are not yet bedridden. About 92 participants will either receive the pump or continue their current drug therapy. The goal is to see which ap…
Matched conditions: END-STAGE HEART FAILURE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New solution may keep donor hearts safer for kids
Disease control Recruiting nowThis study tests a new liquid (Custodiol-N) used to preserve donor hearts before transplant in children. 15 children receiving their first heart transplant will be randomly assigned to get a heart stored in either the new or standard solution. The main goal is to check if the new…
Matched conditions: END-STAGE HEART FAILURE
Phase: PHASE2 • Sponsor: Dr. F. Köhler Chemie GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study aims to simplify heart monitoring for pump patients
Diagnosis Recruiting nowThis pilot study explores whether data from the HeartMate 3 heart pump can be used to monitor heart function without invasive tests or frequent imaging. Researchers will compare high-resolution pump data with standard echocardiograms and ECGs in 60 patients with end-stage heart f…
Matched conditions: END-STAGE HEART FAILURE
Sponsor: Thomas Schlöglhofer, PhD, MSc • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Heart pump study tracks Long-Term survival in failing hearts
Knowledge-focused Recruiting nowThis study follows 300 adults with end-stage heart failure who receive a left ventricular assist device (LVAD) as part of their routine care. Researchers will track survival, complications, and hospital readmissions over 3-5 years, and analyze heart tissue and blood samples to fi…
Matched conditions: END-STAGE HEART FAILURE
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC